Please join Reps. Johnson and Meng in signing a letter to Director Mick Mulvaney asking to raise funding for the Division of Viral Hepatitis at the Centers for Disease Control and Prevention (CDC) to $134 million, and to include $40 million to fully fund
the recently passed program to eliminate opioid-related infectious diseases within the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018 (H.R. 6).
Please join Reps. Johnson and Meng in signing a letter to Director Mick Mulvaney asking to raise funding for the Division of Viral Hepatitis at the Centers for Disease Control and Prevention (CDC) to $134 million, and to include $40 million to fully fund
the recently passed program to eliminate opioid-related infectious diseases within the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018 (H.R. 6).
Please join Reps. Johnson and Meng in signing a letter to Director Mick Mulvaney asking to raise funding for the Division of Viral Hepatitis at the Centers for Disease Control and Prevention (CDC) to $134 million, and to include $40 million to fully fund
the recently passed program to eliminate opioid-related infectious diseases within the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018 (H.R. 6).
Please join Reps. Johnson and Meng in signing a letter to Director Mick Mulvaney asking to raise funding for the Division of Viral Hepatitis at the Centers for Disease Control and Prevention (CDC) to $134 million, and to include $40 million to fully fund
the recently passed program to eliminate opioid-related infectious diseases within the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018 (H.R. 6).
Please join Reps. Johnson and Meng in signing a letter to Director Mick Mulvaney asking to raise funding for the Division of Viral Hepatitis at the Centers for Disease Control and Prevention (CDC) to $134 million, and to include $40 million to fully fund
the recently passed program to eliminate opioid-related infectious diseases within the Substance-Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act of 2018 (H.R. 6).
Please join me in designating and celebrating October 17 as “National Vitiligo Awareness Day.” As a member of the Vitiligo community, it is especially important to me to provide this recognition for others also affected by this condition.
Please join me in designating and celebrating October 17 as “National Vitiligo Awareness Day.” As a member of the Vitiligo community, it is especially important to me to provide this recognition for others also affected by this condition.
By now you should have received an invitation from the Environmental and Energy Study Institute to attend a briefing entitled:
Decommissioning Nuclear Power Plants: What Congress, Federal Agencies and Communities Need to Know.
Contact eDC Support
Contact eDC Support